Objective: To retrospectively review the causes of categorization errors using O-RADS-MRI score and to determine the presumptive causes of these misclassifications.Methods: EURAD database was retrospectively queried to identify misclassified lesions. In this cohort, 1194 evaluable patients with 1502 pelvic masses (277 malignant/1225 benign lesions) underwent standardized MRI to characterize adnexal masses with histology or 2 years follow-up as reference standard. An expert radiologist reviewed cases with two junior radiologists and lesions termed misclassified if malignant lesion was scored≤ 3, a benign lesion was scored≥4, the site of origin was incorrect, or a non-adnexal mass was incorrectly categorized as benign or malignant.Results: There were 139/1502 (9.2%) misclassified masses in 116 women including 109 adnexal and 30 non-adnexal masses. False negative cases corresponded to 16 borderline or invasive malignant adnexal masses rated score≤3 (16/139,11.5%). False positive cases corresponded to 88 benign masses were rated score 4 (67/139,48.2%) or 5 (18/139,12.9%) or considered as suspicious non-adnexal lesions (3/139,2.2%). Misclassifications were only due to origin error in 12 adnexal masses (8 benign, 4 malignant) (8.6%,12/139) and 23 nonadnexal masses (18 benign, 5 malignant,16.5%,23/139) perceived respectively as non-adnexal and adnexal masses. Interpretive errors (n=104), failure to recognize technical insufficient exams (n=9) and perceptual errors (n=4) were found. Most interpretive were due to misinterpretation of solid tissue or incorrect assignment of mass origin. 84/139 cases were correctly reclassified by the readers with strict adherence to the score rules. Conclusion:Most errors were due to misinterpretation of solid tissue or incorrect assignment of mass origin..
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.